Squamous cell carcinoma of the urinary bladder: Systematic review of clinical characteristics and therapeutic approaches

Jeremy W. Martin, Estrella M. Carballido, Ahmed Ahmed, Bilal Farhan, Rahul Dutta, Cody Smith, Ramy F. Youssef

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

Objective To highlight the current understanding of the epidemiology, clinicopathological characteristics, and management of squamous cell carcinoma (SCC) of the bladder, as it accounts for 2–5% of bladder tumours, with a focus on non-bilharzial-associated SCC (NB-SCC). The standard treatment for bladder SCC remains radical cystectomy (RC). We present an updated clinical profile of bladder SCC and a review of NB-SCC therapeutic approaches, including RC, neoadjuvant and adjuvant treatments, radiotherapy, chemotherapy, and immunotherapy. Methods Using search terms relating to SCC, urinary bladder, and treatment modalities, we performed a search of the PubMed and Embase databases to identify NB-SCC treatment approaches and outcomes. Peer-reviewed English language reports from 1975 to present assessing SCC management were included. Two authors independently screened and extracted the data. Results Of the 806 articles screened, 10 met the pre-defined inclusion criteria. RC was performed in seven of the 10 studies. Although radiotherapy alone yielded poor outcomes, preoperative radiotherapy and RC were associated with improved survival. There is little evidence supporting the use of chemotherapy in NB-SCC, and its efficacy in relation to RC is not known. Conclusion Based on current literature, there is insufficient evidence to provide a treatment recommendation for NB-SCC. Whilst RC is the standard of care, the role of preoperative radiotherapy should be revisited and compared to RC alone. Additional studies incorporating multimodal approaches, contemporary radiation techniques, and systemic therapies are warranted. Immunotherapy as a treatment for bladder SCC has yet to be investigated.

Original languageEnglish (US)
Pages (from-to)183-191
Number of pages9
JournalArab Journal of Urology
Volume14
Issue number3
DOIs
StatePublished - Sep 1 2016
Externally publishedYes

Fingerprint

Cystectomy
Squamous Cell Carcinoma
Urinary Bladder
Radiotherapy
Immunotherapy
Therapeutics
Drug Therapy
Adjuvant Radiotherapy
Neoadjuvant Therapy
Standard of Care
PubMed
Urinary Bladder Neoplasms
Epidemiology
Language
Databases
Radiation

Keywords

  • Bilharzial
  • Bladder
  • Radical cystectomy
  • Radiotherapy
  • Squamous cell carcinoma (SCC)

ASJC Scopus subject areas

  • Urology

Cite this

Squamous cell carcinoma of the urinary bladder : Systematic review of clinical characteristics and therapeutic approaches. / Martin, Jeremy W.; Carballido, Estrella M.; Ahmed, Ahmed; Farhan, Bilal; Dutta, Rahul; Smith, Cody; Youssef, Ramy F.

In: Arab Journal of Urology, Vol. 14, No. 3, 01.09.2016, p. 183-191.

Research output: Contribution to journalReview article

Martin, Jeremy W. ; Carballido, Estrella M. ; Ahmed, Ahmed ; Farhan, Bilal ; Dutta, Rahul ; Smith, Cody ; Youssef, Ramy F. / Squamous cell carcinoma of the urinary bladder : Systematic review of clinical characteristics and therapeutic approaches. In: Arab Journal of Urology. 2016 ; Vol. 14, No. 3. pp. 183-191.
@article{9261949bbb714c33a53c20630aebd0c9,
title = "Squamous cell carcinoma of the urinary bladder: Systematic review of clinical characteristics and therapeutic approaches",
abstract = "Objective To highlight the current understanding of the epidemiology, clinicopathological characteristics, and management of squamous cell carcinoma (SCC) of the bladder, as it accounts for 2–5{\%} of bladder tumours, with a focus on non-bilharzial-associated SCC (NB-SCC). The standard treatment for bladder SCC remains radical cystectomy (RC). We present an updated clinical profile of bladder SCC and a review of NB-SCC therapeutic approaches, including RC, neoadjuvant and adjuvant treatments, radiotherapy, chemotherapy, and immunotherapy. Methods Using search terms relating to SCC, urinary bladder, and treatment modalities, we performed a search of the PubMed and Embase databases to identify NB-SCC treatment approaches and outcomes. Peer-reviewed English language reports from 1975 to present assessing SCC management were included. Two authors independently screened and extracted the data. Results Of the 806 articles screened, 10 met the pre-defined inclusion criteria. RC was performed in seven of the 10 studies. Although radiotherapy alone yielded poor outcomes, preoperative radiotherapy and RC were associated with improved survival. There is little evidence supporting the use of chemotherapy in NB-SCC, and its efficacy in relation to RC is not known. Conclusion Based on current literature, there is insufficient evidence to provide a treatment recommendation for NB-SCC. Whilst RC is the standard of care, the role of preoperative radiotherapy should be revisited and compared to RC alone. Additional studies incorporating multimodal approaches, contemporary radiation techniques, and systemic therapies are warranted. Immunotherapy as a treatment for bladder SCC has yet to be investigated.",
keywords = "Bilharzial, Bladder, Radical cystectomy, Radiotherapy, Squamous cell carcinoma (SCC)",
author = "Martin, {Jeremy W.} and Carballido, {Estrella M.} and Ahmed Ahmed and Bilal Farhan and Rahul Dutta and Cody Smith and Youssef, {Ramy F.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1016/j.aju.2016.07.001",
language = "English (US)",
volume = "14",
pages = "183--191",
journal = "Arab Journal of Urology",
issn = "2090-598X",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Squamous cell carcinoma of the urinary bladder

T2 - Systematic review of clinical characteristics and therapeutic approaches

AU - Martin, Jeremy W.

AU - Carballido, Estrella M.

AU - Ahmed, Ahmed

AU - Farhan, Bilal

AU - Dutta, Rahul

AU - Smith, Cody

AU - Youssef, Ramy F.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Objective To highlight the current understanding of the epidemiology, clinicopathological characteristics, and management of squamous cell carcinoma (SCC) of the bladder, as it accounts for 2–5% of bladder tumours, with a focus on non-bilharzial-associated SCC (NB-SCC). The standard treatment for bladder SCC remains radical cystectomy (RC). We present an updated clinical profile of bladder SCC and a review of NB-SCC therapeutic approaches, including RC, neoadjuvant and adjuvant treatments, radiotherapy, chemotherapy, and immunotherapy. Methods Using search terms relating to SCC, urinary bladder, and treatment modalities, we performed a search of the PubMed and Embase databases to identify NB-SCC treatment approaches and outcomes. Peer-reviewed English language reports from 1975 to present assessing SCC management were included. Two authors independently screened and extracted the data. Results Of the 806 articles screened, 10 met the pre-defined inclusion criteria. RC was performed in seven of the 10 studies. Although radiotherapy alone yielded poor outcomes, preoperative radiotherapy and RC were associated with improved survival. There is little evidence supporting the use of chemotherapy in NB-SCC, and its efficacy in relation to RC is not known. Conclusion Based on current literature, there is insufficient evidence to provide a treatment recommendation for NB-SCC. Whilst RC is the standard of care, the role of preoperative radiotherapy should be revisited and compared to RC alone. Additional studies incorporating multimodal approaches, contemporary radiation techniques, and systemic therapies are warranted. Immunotherapy as a treatment for bladder SCC has yet to be investigated.

AB - Objective To highlight the current understanding of the epidemiology, clinicopathological characteristics, and management of squamous cell carcinoma (SCC) of the bladder, as it accounts for 2–5% of bladder tumours, with a focus on non-bilharzial-associated SCC (NB-SCC). The standard treatment for bladder SCC remains radical cystectomy (RC). We present an updated clinical profile of bladder SCC and a review of NB-SCC therapeutic approaches, including RC, neoadjuvant and adjuvant treatments, radiotherapy, chemotherapy, and immunotherapy. Methods Using search terms relating to SCC, urinary bladder, and treatment modalities, we performed a search of the PubMed and Embase databases to identify NB-SCC treatment approaches and outcomes. Peer-reviewed English language reports from 1975 to present assessing SCC management were included. Two authors independently screened and extracted the data. Results Of the 806 articles screened, 10 met the pre-defined inclusion criteria. RC was performed in seven of the 10 studies. Although radiotherapy alone yielded poor outcomes, preoperative radiotherapy and RC were associated with improved survival. There is little evidence supporting the use of chemotherapy in NB-SCC, and its efficacy in relation to RC is not known. Conclusion Based on current literature, there is insufficient evidence to provide a treatment recommendation for NB-SCC. Whilst RC is the standard of care, the role of preoperative radiotherapy should be revisited and compared to RC alone. Additional studies incorporating multimodal approaches, contemporary radiation techniques, and systemic therapies are warranted. Immunotherapy as a treatment for bladder SCC has yet to be investigated.

KW - Bilharzial

KW - Bladder

KW - Radical cystectomy

KW - Radiotherapy

KW - Squamous cell carcinoma (SCC)

UR - http://www.scopus.com/inward/record.url?scp=84991490390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991490390&partnerID=8YFLogxK

U2 - 10.1016/j.aju.2016.07.001

DO - 10.1016/j.aju.2016.07.001

M3 - Review article

AN - SCOPUS:84991490390

VL - 14

SP - 183

EP - 191

JO - Arab Journal of Urology

JF - Arab Journal of Urology

SN - 2090-598X

IS - 3

ER -